Effectiveness and Feasibility of ChatGPT-Based Support for Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention

Evaluation of the Effectiveness and Feasibility of ChatGPT-Based Life Support for Patients with Acute Coronary Syndrome After Percutaneous Coronary Intervention - CHAT-ACS Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000060794

Enrollment

Registered

2026-03-02

Start date

2026-03-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ten patients with ACS who attended their first outpatient visit following PCI

Interventions

Using ChatGPT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Ten patients with ACS attending their first outpatient visit after PCI

Exclusion criteria

Exclusion criteria: Patients who are unable to provide informed responses due to communication difficulties and those who have been diagnosed with depression by a physician at the time of the outpatient visit.

Design outcomes

Primary

Measure	Time frame
HADS depression subscale score after two weeks of AI-based support	—

Secondary

Measure	Time frame
Quality of life assessed using the WHOQOL-26 (WHO/Tasaki et al.), specifically the item "How would you rate your quality of life?" , as well as system usability and participants' willingness to use the AI-based support again, evaluated two weeks after initiation of AI use.	—

Countries

Japan

Contacts

Public ContactMana DOI

Tokyo Healthcare University Chiba Faculty of Nursing, Department of Gerontological Nursing & Home Care Nursing

m-doi@thcu.ac.jp+81-47-495-7751

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026